AstraZeneca to acquire 55% stake in Acerta Pharma
Following the news earlier this week that AstraZeneca had been in acquisition talks with Acerta Pharma, AstraZeneca today announced that it is to invest in a majority equity stake in the company.
List view / Grid view
Following the news earlier this week that AstraZeneca had been in acquisition talks with Acerta Pharma, AstraZeneca today announced that it is to invest in a majority equity stake in the company.
AstraZeneca today confirmed that it is in talks with Acerta Pharma to acquire the company in a potential deal worth $5 billion.
Sartorius Stedim Biotech (SSB), a leading international supplier for the pharma and biotech industries, acquired Cellca GmbH based in Laupheim, Germany. Founded in 2005, the company with around 30 employees generated sales revenue of approximately 6 million euros in 2014.
26 May 2015 | By Victoria White
AbbVie has completed the acquisition of Pharmacyclics, enhancing AbbVie's scientific and commercial presence in the haematological oncology market...
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.
16 December 2014 | By Abbott
Abbott announced that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation ("ALH"), has commenced a tender offer (the "U.S. Notes Offer"), in which it is offering to purchase for cash any and all of the outstanding $300 million aggregate principal amount of 5.125% Senior Notes due…
15 December 2014 | By Abbott
Abbott announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer...
24 October 2014 | By GlobalData
The recent termination of AbbVie’s deal to acquire Shire makes this pharmaceuticals’ first major casualty of new US tax inversion legislation, and has jolted the industry out of its reverie, according to an analyst with research and consulting firm GlobalData.
29 September 2014 | By Abbott
Abbott has acquired control of CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence and further expanding the company's presence in fast-growing markets...
24 September 2014 | By Abbott
Abbott announced the expiration of the tender offer for the purchase from U.S. holders of the ordinary shares of CFR Pharmaceuticals S.A., a Chilean corporation...
Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, and Life Technologies Corporation (NASDAQ: LIFE), a leading life sciences company, have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the…
Metrohm and FOSS have entered into a strategic alliance strengthening the two companies’ leading positions in their respective key markets. In this strategic alliance, Metrohm will become the sole global distributor of FOSS NIR instruments for the chemical, petrochemical, pharmaceutical, and environmental sectors.
Corning Incorporated (NYSE: GLW) announced today that it has reached a definitive agreement with BD (Becton, Dickinson and Company) (NYSE:BDX) to acquire the majority of its Discovery Labware unit for approximately $730 million in cash. The acquisition is expected to be completed later this year, subject to customary closing conditions,…
Corning Incorporated (NYSE:GLW) announced today that it has reached an agreement with the shareholders of Plaslab S.A.S. to acquire all outstanding shares of the company. Assuming certain closing conditions are met, the acquisition is expected to be completed in the fourth quarter of 2010.